COVID-19 – mycolab.ai

Prognostic model for gastric cancer patients with COVID-19 and network pharmacology study on treatment by lentinan

mycolabadmin

This study investigated how lentinan, a compound from shiitake mushrooms, might help treat patients who have both gastric cancer and COVID-19. Researchers identified five genes that predict patient outcomes and found that lentinan may work by controlling immune cell activity and reducing inflammation. The study suggests lentinan could be a useful additional treatment for this challenging combination of diseases, though more research is needed.

Errors in the Author Affiliations

mycolabadmin

This is a correction notice for a research study about psilocybin therapy used to treat depression in healthcare workers during the COVID-19 pandemic. The original article had several incorrect author affiliations that have now been corrected to properly list their departments at the University of Washington School of Medicine.

Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial

mycolabadmin

Researchers tested whether combining psilocybin therapy with mindfulness training could better treat depression and burnout in frontline healthcare workers than mindfulness training alone. Twenty-five doctors and nurses participated in the study, with some receiving mindfulness training combined with psilocybin therapy in a group setting, while others received mindfulness training only. After two weeks, those who received the combined treatment showed significantly greater improvements in depression symptoms and burnout, with no serious side effects reported. This suggests that psilocybin-assisted therapy combined with mindfulness training could be a promising treatment for depression and burnout among healthcare professionals.

Antioxidant Activity of Mushroom Extracts/Polysaccharides—Their Antiviral Properties and Plausible AntiCOVID-19 Properties

mycolabadmin

Mushrooms contain special compounds called polysaccharides that act as natural antioxidants and can fight viruses. These compounds help boost the immune system and reduce inflammation in the body. While mushrooms have shown promise against various viruses including COVID-19, more research is needed to fully develop them as treatments.

The Rising Threat of Mucormycosis: Oman’s Experience Before and During the COVID-19 Pandemic

mycolabadmin

Mucormycosis is a serious fungal infection that became much more common in Oman during the COVID-19 pandemic. Most patients had diabetes and nearly half had COVID-19, with very high death rates. The infection primarily affects the sinuses and brain, and requires aggressive treatment with surgery and antifungal medications. This study shows doctors need better tools to detect and treat this dangerous infection, especially during health crises.

Sarocladium implicatum: an unusual agent of opportunistic infection in a COVID-19 patient

mycolabadmin

A patient hospitalized with severe COVID-19 developed an unusual infection caused by a mold called Sarocladium implicatum, which typically affects plants. Due to weakened immune system from his illness and medications, the fungus spread to his bloodstream and lungs, causing persistent fever and a cavity in his lung. After molecular testing identified the fungus, he was treated with an antifungal medication called voriconazole, which successfully cured the infection.

The Prognostic Value of (1→3)-β-D-Glucan in COVID-19 Patients with and Without Secondary Fungal Disease

mycolabadmin

During COVID-19 infection, a fungal marker called beta-D-glucan (BDG) in the blood can predict patient survival even without a diagnosed fungal infection. Researchers found that COVID-19 patients with high BDG levels had a 91% death rate if not treated with antifungal drugs, but this dropped to 50% when antifungal therapy was given. The high BDG levels trigger a strong inflammatory response in the body that worsens disease severity, making BDG a valuable warning sign for doctors treating critically ill COVID-19 patients.

Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases

mycolabadmin

This article explores how traditional medicine systems like Ayurveda and Chinese Medicine can help prevent and treat infectious diseases, including COVID-19. These ancient healing systems use natural herbs and lifestyle changes to boost immunity and fight infections more holistically. Scientific evidence shows that natural compounds like curcumin from turmeric have real antiviral and anti-inflammatory properties. By combining traditional knowledge with modern research, we may develop better treatments for emerging diseases.

Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era

mycolabadmin

This article reviews how beta-glucans, natural compounds found in mushrooms, can boost your immune system and help fight diseases including COVID-19. These compounds work by activating immune cells and reducing dangerous inflammatory responses in the body. Mushroom beta-glucans are safe, easy to take by mouth, and available in many edible mushroom varieties like shiitake and oyster mushrooms.

Mycobiome analyses of critically ill COVID-19 patients

mycolabadmin

This study examined fungal infections in severely ill COVID-19 patients treated in intensive care units across Europe. Researchers found that a dangerous mold called Aspergillus fumigatus was more common in patients who died and less common in those treated with azole antifungal drugs. The findings suggest that giving antifungal medications to critically ill COVID-19 patients when they arrive at the hospital might help prevent fungal-related deaths.

Research Topic: COVID-19